Congressman calls for SEC investigation into leak about possible coronavirus drug

A video touting the efficacy of the drug remdesivir in treating Covid-19 was leaked, sending the manufacturer's stock soaring.

(CNN)A congressman on Friday called for the Securities and Exchange Commission to investigate the leak of a video showing physicians at the University of Chicago speaking enthusiastically about an experimental drug to treat Covid-19.

Texas Democrat Rep. Lloyd Doggett, chair of the House Ways and Means Health Subcommittee, said the leak was "so significant" at a time when the world is "so desperate to find a cure."
University of Chicago physicians are helping test remdesivir, an antiviral drug made by Gilead Sciences in patients with Covid-19.
      Dr. Kathleen Mullane, an infectious disease specialist at the University of Chicago, is leading the clinical trial funded by Gilead.
        "The best news is that most of our patients have already been discharged, which is great. We've only had two patients perish," Mullane is quoted as saying in the video.
          The video was leaked to STAT News, a health news website, which published it Thursday afternoon. The story was picked up widely by other news outlets, including CNN, and Gilead stock soared 12%.